Vaccinia Related Kinase 2 (VRK2) (Middle Region) Peptide
VRK2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all VRK2 products
- VRK2 (Vaccinia Related Kinase 2 (VRK2))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- YKNPDQVYLA DYGLSYRYCP NGNHKQYQEN PRKGHNGTIE FTSLDAHKGV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- VRK2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- VRK2 (Vaccinia Related Kinase 2 (VRK2))
- Background
-
This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity.
Protein Size: 454 - Gene ID
- 7444
- NCBI Accession
- NM_001130480, NP_001123952
-
You are here:
